Company

Neogene Therapeutics, Inc.

Neogene Therapeutics develops T-cell therapies for cancer treatment.

About

Founded in 2018 and based in Amsterdam, Netherlands, Neogene Therapeutics develops cell therapies for cancer using T-cell technologies. AstraZeneca acquired the company for USD 200.00 mn on November 29, 2022.

1Funding rounds

8Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in